-
The collaborative development between Oxford Nanopore and Wasatch BioLabs marks an exciting milestone in the field of epigenetics and signals a commitment to empowering researchers with innovative, reliable tools. As the product nears its anticipated market release, the scientific community awaits a new era of discovery and understanding in methylation research, fueled by real-time, comprehensive insights into the methylome.
Nov 12, 2024
-
Nov 10, 2024
-
MMS has announced that its regulatory team has been selected as one of three top finalists in the Fierce CRO Awards for Leadership in Regulatory Compliance.
Nov 11, 2024
-
Octalsoft, a global leader in clinical trial and healthcare technology solutions, is proud to announce its recognition as a Times Gujarat Icon 2024 Award winner, acknowledging the company’s exceptional contributions to the technology and healthcare sectors.
Nov 10, 2024
-
PathAI’s solution facilitates this analysis directly from routine H&E pathology images from standard imaging platforms, democratizing access to key insights into tumor biology and therapeutic responses without the need of custom microscopy.
Nov 3, 2024
-
Sunbird’s diagnostic technology classified Parkinson’s disease-positive blood samples with 86% accuracy through the direct detection of aggregated alpha synuclein proteins.
Oct 31, 2024
-
PathAI, a leader in digital and AI-powered pathology solutions, and VIZIA Diagnostics, a GI- specialized pathology laboratory based in Alpharetta, Georgia, have announced that VIZIA has adopted PathAI’s AISightⓇ1 Image Management System (IMS) and AI technology to advance the precision and operational efficiency of its pathology services.
Oct 30, 2024
-
Takara Bio Europe has announced the expansion of its Gothenburg facility, with the addition of a custom manufacturing lab. This new facility now offers a comprehensive array of customised molecular biology products, including PCR and qPCR enzymes, servicing the molecular biology needs of academic researchers, diagnostic labs, and biotech companies across EMEA, producing up to 600,000 reactions per week.
With these expanded capabilities, customers can expect faster deliveries, personalised service, and real-time access to technical expertise, ensuring projects move forward efficiently while supporting sustainability goals through reduced carbon emissions.
Oct 27, 2024
-
RBQM innovator CluePoints has today announced that Richard Young has been appointed as its new Chief Strategy Officer. With 30 years of experience in clinical data management, Richard is an expert in his field.
Oct 27, 2024
-
Coronado Research announced today that Professor Jennifer Visser-Rogers has been appointed as Chief Scientific Officer.
Oct 23, 2024
-
CluePoints, provider of leading statistical and AI-driven software solutions, has been recognized for its impressive growth at the BVA Private Equity Awards.
Oct 22, 2024
-
PathAI, a global leader in AI-powered digital pathology, today announced the launch of two new features on its AISight®1 Image Management System (IMS): Guided Algorithm Review and Z-Stack Image Support. These enhancements reflect PathAI’s ongoing commitment to empowering pathologists with innovative tools that enhance pathology interpretation, optimize laboratory operations, and lay the foundation for broader adoption of AI tools in the field of pathology.
Oct 22, 2024
-
Biopharma PEG has launched a range of polyethylene glycol (PEG) products for PEGylation, improving drug efficacy. With over 40 approved PEGylated drugs, interest in monodispersed PEGs is growing, as seen with Movantik. Biopharma PEG is dedicated to supporting PEGylated drug development.
Oct 22, 2024
-
Proscia was named to KLAS Research’s 2024 Emerging Solutions Top 20 list of technologies best positioned to impact the Quadruple Aim of Healthcare. Its Concentriq® software platform was selected by healthcare leaders across the United States for improving patient outcomes. Awardees were celebrated at the HLTH USA event in Las Vegas, Nevada.
Oct 21, 2024
-
Augurex Life Sciences Corp. has announced a new partnership with ARUP Laboratories to launch the 14-3-3η (eta) test, aimed at enhancing the early diagnosis and management of rheumatoid arthritis (RA). The 14-3-3η biomarker is associated with more severe RA and higher risk of joint damage, making it a critical tool for early intervention. By expanding access to this test, clinicians across the U.S. can improve personalized care and outcomes for RA patients. This collaboration reflects a shared commitment between Augurex and ARUP to advance autoimmune diagnostics and patient health.
Oct 20, 2024
-
Oct 16, 2024
-
Yourgene Health announces that it has received accreditation under the new EU requirements of the in vitro diagnostic regulation (IVDR) for the Yourgene® Cystic Fibrosis Base assay.
Oct 16, 2024
-
Healthcasts, the leading online community for healthcare professional consultation and real-world experience, today announced the appointment of Max Baumer, CPA, as Chief Operating Officer and Chief Financial Officer. Baumer has spent over a decade overseeing finance and operations for companies experiencing exceptional growth including large hospital systems and healthcare staffing companies, making him uniquely positioned to bridge financial and operational duties in his role at Healthcasts.
Oct 15, 2024
-
Oct 14, 2024
-
AI-Sight – the University of Liverpool AI diagnostic technology spin-out based at Sci-Tech Daresbury – has successfully concluded its seven-figure equity funding round from experienced healthcare industry figures and investors.
Oct 8, 2024